4Q sales, trends for key Bristol-Myers medicines 

Global sales of key Bristol-Myers Squibb drugs in 2011's fourth quarter:

Drug name Use???????????????????2011??????????Change?from?2010

Plavix Blood?thinner?????????$1.67?billion?Down?3?percent

Abilify Psychiatric?disorders?$737?million??Up?4?percent

Reyataz HIV/AIDS??????????????$416?million??Up?11?percent

Sustiva HIV/AIDS??????????????$412?million??Up?14?percent

Baraclude Hepatitis?B???????????$318?million??Up?20?percent

Orencia Rheumatoid?arthritis??$257?million??Up?27?percent?

Sprycel Leukemia??????????????$227?million??Up?34?percent

Avapro/Avalide High?blood?pressure???$195?million??Down?23?percent???

Onglyza Type?2?diabetes???????$153?million??Up?110?percent

Yervoy Melanoma??????????????$144?million??N.A.?(new?drug)

___

Source: Bristol-Myers Squibb Co.

Pin It
Favorite

More by The Associated Press

Latest in Health & Fitness

© 2018 The San Francisco Examiner

Website powered by Foundation